These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 20002653

  • 1. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):789-96. PubMed ID: 20002653
    [Abstract] [Full Text] [Related]

  • 2. The inflammatory response in mild and in severe psoriasis.
    Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F.
    Br J Dermatol; 2004 May; 150(5):917-28. PubMed ID: 15149504
    [Abstract] [Full Text] [Related]

  • 3. Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2012 Feb 01; 13(1):37-47. PubMed ID: 21888450
    [Abstract] [Full Text] [Related]

  • 4. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2010 Dec 01; 11(6):423-32. PubMed ID: 20429617
    [Abstract] [Full Text] [Related]

  • 5. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F.
    Br J Dermatol; 2008 Aug 01; 159(2):322-30. PubMed ID: 18503600
    [Abstract] [Full Text] [Related]

  • 6. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.
    Kanelleas A, Liapi C, Katoulis A, Stavropoulos P, Avgerinou G, Georgala S, Economopoulos T, Stavrianeas NG, Katsambas A.
    Clin Exp Dermatol; 2011 Dec 01; 36(8):845-50. PubMed ID: 21790728
    [Abstract] [Full Text] [Related]

  • 7. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
    Serwin AB, Wasowicz W, Chodynicka B.
    Nutrition; 2006 Sep 01; 22(9):860-4. PubMed ID: 16829029
    [Abstract] [Full Text] [Related]

  • 8. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
    Coimbra S, Oliveira H, Belo L, Figueiredo A, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2013 Feb 01; 14(1):49-53. PubMed ID: 23329079
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan 01; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of soluble CD163 as a marker of inflammation in psoriasis.
    Feighery C, Dunne J, Bingham EA, Feighery CF.
    Clin Exp Dermatol; 2011 Mar 01; 36(2):201-3. PubMed ID: 21323937
    [Abstract] [Full Text] [Related]

  • 11. Circulating cell-free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy.
    Coimbra S, Catarino C, Costa E, Oliveira H, Figueiredo A, Rocha-Pereira P, Santos-Silva A.
    Br J Dermatol; 2014 Apr 01; 170(4):939-42. PubMed ID: 24245854
    [Abstract] [Full Text] [Related]

  • 12. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J.
    Int J Clin Pharmacol Res; 2003 Apr 01; 23(2-3):47-51. PubMed ID: 15018018
    [Abstract] [Full Text] [Related]

  • 13. Goeckerman's therapy for psoriasis with special reference to serum pentraxin 3 level.
    Ctirad A, Lenka B, David P, Zdenek F, Kveta H, Karel E, Jan K.
    Int J Dermatol; 2008 Oct 01; 47(10):1011-4. PubMed ID: 18986345
    [Abstract] [Full Text] [Related]

  • 14. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
    Boehncke S, Salgo R, Garbaraviciene J, Beschmann H, Hardt K, Diehl S, Fichtlscherer S, Thaçi D, Boehncke WH.
    J Eur Acad Dermatol Venereol; 2011 Oct 01; 25(10):1187-93. PubMed ID: 21241371
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
    Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Ettler K, Fiala Z.
    Int J Dermatol; 2008 Aug 01; 47(8):800-5. PubMed ID: 18717859
    [Abstract] [Full Text] [Related]

  • 16. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
    Sivanesan SP, Gattu S, Hong J, Chavez-Frazier A, Bandow GD, Malick F, Kricorian G, Koo J.
    J Am Acad Dermatol; 2009 Nov 01; 61(5):793-8. PubMed ID: 19766350
    [Abstract] [Full Text] [Related]

  • 17. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
    Akman A, Dicle O, Yilmaz F, Coskun M, Yilmaz E.
    Photodermatol Photoimmunol Photomed; 2008 Jun 01; 24(3):123-7. PubMed ID: 18477130
    [Abstract] [Full Text] [Related]

  • 18. Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVA.
    Neumann NJ, Mahnke N, Korpusik D, Stege H, Ruzicka T.
    Acta Derm Venereol; 2006 Jun 01; 86(1):22-4. PubMed ID: 16585984
    [Abstract] [Full Text] [Related]

  • 19. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
    Torras H, Aliaga A, López-Estebaranz JL, Hernández I, Gardeazabal J, Quintanilla E, Mascaró JM.
    J Dermatolog Treat; 2004 Apr 01; 15(2):98-103. PubMed ID: 15204160
    [Abstract] [Full Text] [Related]

  • 20. A single blind randomized clinical study: the efficacy of isotretinoin plus narrow band ultraviolet B in the treatment of psoriasis vulgaris.
    Mortazavi H, Khezri S, Hosseini H, Khezri F, Vasigh M.
    Photodermatol Photoimmunol Photomed; 2011 Jun 01; 27(3):159-61. PubMed ID: 21535171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.